Ivan Budyak
Senior Director, Analytical Development Biophysical Characterization Eli Lilly and Company
Ivan Budyak, Senior Director of Analytical Development and Biophysical Characterization at Eli Lilly and Company, is a seasoned protein sciences leader with deep expertise across expression, purification, biochemistry, and biophysical analysis. He has extensive experience producing soluble and membrane proteins across multiple expression systems and scaling bacterial fermentation to 200 L. Ivan’s broad analytical toolkit spans chromatography, mass spectrometry, SAXS/SANS, X-ray data collection, and advanced spectroscopic methods. With additional strengths in Python-based bioinformatics, he integrates structural, functional, and biophysical insights to drive molecular understanding and ensure smooth translation from discovery into development. He will speak on connecting discovery insights to development success.
